Fms-like tyrosine kinase (Flt)-4 signaling participates in osteoclast differentiation in osteopetrotic (op/op) mice

Biomedical Research

Volumn 30, Issue 1, 2009, Pages 31-37

  Tsuka, Natsumi ^a   Motokawa, Masahide ^a   Kaku, Masato ^a   Kawata, Toshitsugu ^a   Fujita, Tadashi ^a   Ohtani, Junji ^a   Koseki, Hiroyuki ^a   Sunagawa, Hiroko ^a   Matsuda, Yayoi ^a   Abedini, Sara ^a   Hayashi, Hidetaka ^a   Tanne, Kazuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; RECOMBINANT VASCULOTROPIN; RECOMBINANT VASCULOTROPIN D; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE FUNCTION; LIGAND BINDING; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOCLAST; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE REMODELING; CELL COUNT; DRUG MECHANISM; FEMALE; MALE; ORTHODONTICS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

MUS;

ANIMALS; CELL DIFFERENTIATION; LIGANDS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; OSTEOCLASTS; OSTEOPETROSIS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 66749094105     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.30.31     Document Type: Article

References (25)

1. Achen MG, Jeltsch M and Kukk E (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc Natl Acad Sci USA 95, 548–553.
2. Alam A, Herault JP, Barron P, Favier B, Fons P, Delesque-Touchard N, Senegas I, Laboudie P, Bonnin J, Cassan C, Savi P, Ruggeri B, Carmeliet P, Bono F and Herbert JM (2004) Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity. Biochem Biophys Res Commun 324, 909–915.
3. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB and Thomas KA (1990) Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87, 1323–1327.
4. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N and Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989–991.
5. Doanes AM, Hegland, DD, Sethi R, Kovesdi I, Bruder JT and Finkel T (1999) VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem Biophys Res Commun 255, 545–548.
6. Felix R, Cecchini MG and Fleisch H (1990) Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127, 2592–2594.
7. Harrington EO, Löffler J, Nelson PR, Kent KC, Simons M and Ware JA (1997) Enhancement of migration by protein kinase Ca and inhibition of proliferation and cell cycle progression by protein kinase CS in capillary endothelial cells. J Biol Chem 272, 7390–7397.
8. Ilan N, Mahooti S and Madri JA (1998) Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 111, 3621–3631.
9. Jussila L and Alitalo K (2002) Vascular growth factors and lymphangiogenesis. Physiol Rev 82, 673–700.
10. Kaku M, Niida S, Kawata T, Maeda N and Tanne K (2000) Dose- and time-dependent changes in osteoclast induction after a single injection of vascular endothelial growth factor in osteopetrotic mice. Biomed Res 21, 67–72
11. Kaku M, Kohno S, Kawata T, Fujita T, Tokimasa C, Tsutsui K and Tanne K (2001) Effects of vascular endothelial growth factor on osteoclast induction during tooth movement in mice. J Dent Res 80, 1880–1883.
12. Kohno S, Kaku M, Tsutsui K, Motokawa M, Ohtani J, Tenjo K, Tohma Y, Tokimasa C, Fujita T, Kawata T and Tanne K (2003) Expression of vascular endothelial growth factor and the effects on bone remodeling during experimental tooth movement. J Dent Res 82, 177–182.
13. Kohno S, Kaku M, Kawata T, Fujita T, Tsutsui K, Ohtani J, Tenjo K, Tohma Y, Motokawa M, Shigekawa M, Kamada H and Tanne K (2005) Neutralizing effects of an anti-vascular endothelial growth factor antibody on tooth movement. Angle Orthod 75, 797–804.
14. Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y and Nishikawa SI (2000) Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96, 546–553.
15. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306–1309.
16. Nakagawa M, Kaneda T, Arakawa T, Morita S, Sato T, Yomada T, Hanada K, Kumegawa M and Hakeda Y (2000) Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473, 161–164.
17. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Nishikawa S and Kodama H (1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190, 293–298.
18. Paavonen K, Puolakkainen P, Jussila L, Jahkola T and Alitalo K (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156, 1499–1504.
19. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H and Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519–524.
20. Takahashi T, Ueno H and Shibuya M (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 2221–2230.
21. Veikkola T, Karkkainen M, Claesson-Welsh L and Alitalo K (2000) Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60, 203–212.
22. Wiktor-Jedrzejczak W, Ahmed A, Szczylik C and Skelly RR (1982) Hematological characterization of congenital osteopetrosis n op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med 156, 1516–1527.
23. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD and Nishikawa S (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442–444.
24. Yoshiji H (1999) Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Res 59, 4413–4418.
25. Yoshino H, Morita I, Murota SI and Ishikawa I (2003) Mechanical stress induces production of angiogenic regulators in cultured human gingival and periodontal ligament fibroblasts. J Periodontal Res 38, 405–410.